187 related articles for article (PubMed ID: 9887220)
21. Incomplete reversal of enoxaparin toxicity by protamine: implications of renal insufficiency, obesity, and low molecular weight heparin sulfate content.
Chawla LS; Moore G; Seneff MG
Obes Surg; 2004 May; 14(5):695-8. PubMed ID: 15186641
[TBL] [Abstract][Full Text] [Related]
22. Flash chronopotentiometric sensing of the polyions protamine and heparin at ion-selective membranes.
Gemene KL; Bakker E
Anal Biochem; 2009 Mar; 386(2):276-81. PubMed ID: 19154727
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms responsible for the failure of protamine to inactivate low-molecular-weight heparin.
Crowther MA; Berry LR; Monagle PT; Chan AK
Br J Haematol; 2002 Jan; 116(1):178-86. PubMed ID: 11841415
[TBL] [Abstract][Full Text] [Related]
24. Reversal of low-molecular-weight heparin anticoagulation by synthetic protamine analogues.
Wakefield TW; Andrews PC; Wrobleski SK; Kadell AM; Fazzalari A; Nichol BJ; Vanderkooi T; Stanley JC
J Surg Res; 1994 Jun; 56(6):586-93. PubMed ID: 8015315
[TBL] [Abstract][Full Text] [Related]
25. Novel concatameric heparin-binding peptides reverse heparin and low-molecular-weight heparin anticoagulant activities in patient plasma in vitro and in rats in vivo.
Schick BP; Maslow D; Moshinski A; San Antonio JD
Blood; 2004 Feb; 103(4):1356-63. PubMed ID: 14576044
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of low-molecular-weight heparin reversal by platelet factor 4.
Fiore MM; Mackie IM
Thromb Res; 2009 May; 124(1):149-55. PubMed ID: 19195682
[TBL] [Abstract][Full Text] [Related]
27. Clinical application of disposable heparin sensors. Blood heparin measurements during open heart surgery.
Yun JH; Lee LM; Wahr JA; Fu B; Meyerhoff ME; Yang VC
ASAIO J; 1995; 41(3):M661-4. PubMed ID: 8573887
[TBL] [Abstract][Full Text] [Related]
28. Improved protamine-sensitive membrane electrode for monitoring heparin concentrations in whole blood via protamine titration.
Ramamurthy N; Baliga N; Wahr JA; Schaller U; Yang VC; Meyerhoff ME
Clin Chem; 1998 Mar; 44(3):606-13. PubMed ID: 9510869
[TBL] [Abstract][Full Text] [Related]
29. Quantitative determination of fucoidan using polyion-sensitive membrane electrodes.
Kim JM; Nguyen L; Barr MF; Morabito M; Stringer D; Fitton JH; Mowery KA
Anal Chim Acta; 2015 Jun; 877():1-8. PubMed ID: 26002205
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the effects of unfractionated heparin and the low-molecular-weight heparins dalteparin and enoxaparin on spontaneous platelet aggregation and adenosine diphosphate activity in platelets during the third trimester of pregnancy.
Ajayi AA; Pharmacols FB; Cooper J; Horn EH; Rubin PC
Methods Find Exp Clin Pharmacol; 2007 Oct; 29(8):539-45. PubMed ID: 18040530
[TBL] [Abstract][Full Text] [Related]
31. Quantitative determination of dextran sulfate and pentosan polysulfate and their binding with protamine using chronopotentiometry with polyion-selective electrodes.
Gordon E; Segal S; Sabou AK; Gemene KL
Anal Chim Acta; 2021 Mar; 1149():338208. PubMed ID: 33551060
[TBL] [Abstract][Full Text] [Related]
32. Analysis of the complex formation of heparin with protamine by light scattering and analytical ultracentrifugation: implications for blood coagulation management.
Maurer J; Haselbach S; Klein O; Baykut D; Vogel V; Mäntele W
J Am Chem Soc; 2011 Feb; 133(4):1134-40. PubMed ID: 21186806
[TBL] [Abstract][Full Text] [Related]
33. Anticoagulation with low-molecular-weight heparin in patients with heart diseases.
Bechtold H; Janssen D
Eur J Med Res; 2004 Apr; 9(4):186-98. PubMed ID: 15210399
[TBL] [Abstract][Full Text] [Related]
34. Measurement of fluorescent-labeled LMM-heparin in biological fluids using protamine-linked microbeads.
Malsch R; Melui D; Piazolo L; Harenberg J; Heene DL
Semin Thromb Hemost; 1997; 23(1):23-30. PubMed ID: 9156407
[TBL] [Abstract][Full Text] [Related]
35. Polycationic calix[8]arenes able to recognize and neutralize heparin.
Mecca T; Consoli GM; Geraci C; La Spina R; Cunsolo F
Org Biomol Chem; 2006 Oct; 4(20):3763-8. PubMed ID: 17024282
[TBL] [Abstract][Full Text] [Related]
36. The role of low-molecular-weight heparins in non-ST-segment elevation acute coronary syndromes.
Nguyen-Ho P; Levine GN
Panminerva Med; 2002 Jun; 44(2):115-22. PubMed ID: 12032429
[TBL] [Abstract][Full Text] [Related]
37. Response characteristics of a reversible electrochemical sensor for the polyion protamine.
Shvarev A; Bakker E
Anal Chem; 2005 Aug; 77(16):5221-8. PubMed ID: 16097762
[TBL] [Abstract][Full Text] [Related]
38. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
Holzheimer RG
Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
[TBL] [Abstract][Full Text] [Related]
39. Ability of low-molecular-weight heparin to alleviate proteinuria by inhibiting respiratory syncytial virus infection.
Guo Y; Wang Z; Dong L; Wu J; Zhai S; Liu D
Nephrology (Carlton); 2008 Oct; 13(7):545-53. PubMed ID: 19161362
[TBL] [Abstract][Full Text] [Related]
40. Product individuality of commercially available low-molecular-weight heparins and their generic versions: therapeutic implications.
Maddineni J; Walenga JM; Jeske WP; Hoppensteadt DA; Fareed J; Wahi R; Bick RL
Clin Appl Thromb Hemost; 2006 Jul; 12(3):267-76. PubMed ID: 16959680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
